Yarrow Bioscience (YARW) Receivables - Net (2017 - 2023)

Yarrow Bioscience (YARW) has reported Receivables - Net for 7 consecutive years, with $250000.0 the latest figure, recorded in Q3 2023.

• For the quarter ending Q3 2023, Receivables - Net fell 46.92% year-over-year to $250000.0; the trailing twelve-month figure through Sep 2023 stood at $250000.0 (down 46.92% YoY), and the FY2022 full-year result was $173000.0, down 97.72% from the prior year.
• Receivables - Net climbed to $250000.0 in Q3 2023 per YARW's latest filing, from $234000.0 in the prior quarter.
• Across five years, Receivables - Net topped out at $15.8 million in Q4 2020 and bottomed at $105000.0 in Q1 2023.
• Historically, Receivables - Net has averaged $5.2 million across 5 years, with a median of $3.5 million in 2020.
• The sharpest annual moves came in 2020 and 2022: Receivables - Net surged 11617.78% in 2020, then plunged 97.72% in 2022.
• Over 5 years, Receivables - Net stood at $135000.0 in 2019, then soared by 11617.78% to $15.8 million in 2020, then plunged by 52.06% to $7.6 million in 2021, then slumped by 97.72% to $173000.0 in 2022, then soared by 44.51% to $250000.0 in 2023.
• According to Business Quant data, Receivables - Net over the past three periods registered $250000.0, $234000.0, and $105000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.